Persistent helped the client streamline their IT portfolio by identifying 2000 applications to be eliminated and 1122 critical upgrades.
Challenges
The client, one of the world’s largest pharmaceutical company, had a huge application portfolio built over the years due to mergers, acquisitions and enterprise upgrades. This application sprawl led to increased application management cost, reduced ROI, unnecessary complexity and security concerns.
With more than 6000 applications in their IT portfolio spread across multiple business units, the client was unable to get a single pane of view to understand the business impact and cost of maintaining these applications. Moreover, legacy applications were slowing down the modernization and transformation journey for the enterprise.
Persistent worked with the client to analyze their current IT landscape. With a tool-based systematic top down approach, we helped the client rationalize their application portfolio.
Our team worked with the client to integrate multiple data sources like CMDB, service requests, user surveys and identified the technical maturity, business impact and maintenance spend of each application. We leveraged a combination of industry best practices and Persistent developed SURE framework and APR tool to help the client analyze existing application portfolio. The framework uses a top down approach to categorize applications and take informed decisions to Sustain, Update, Re-platform or Eliminate applications. This helped us evaluate 8513 applications for rationalization and develop a single pane view of entire application portfolio.
Outcomes
- 2000 redundant applications identified to be eliminated
- 1122 critical apps to be upgraded to deliver higher business value
- Aligned the digital application landscape, strategy, processes, and assets to a leaner growth focused biopharma digital business strategy and investment plans
